RPRX · earnings call history
Royalty Pharma Q1 FY26 — Strong Growth and Strategic Investments
Read the briefRoyalty Pharma Q4 FY25 — Strong Growth and Capital Deployment Ahead of Schedule
Read the briefRoyalty Pharma Q3 FY25 — Strong Royalty Acquisitions and Raised Guidance
Read the briefRoyalty Pharma Q4 FY24 — Strong Performance, Internalization, and Capital Deployment
Read the briefBrowse all US companies on the earnings-call register.